Ketchum wins International Consultancy of the Year award

November 3, 2011
Medical Communications Ketchum, Ketchum Pleon, PR

Ketchum Pleon has accepted the International Consultancy of the Year award on behalf of the global firm Ketchum at the …

GSK pays $3 billion to settle US marketing probe

November 3, 2011
Sales and Marketing GSK, compliance, federal investigation

GlaxoSmithKline has agreed to pay $3 billion to settle US government investigations into the sales and marketing of diabetes drug …

Synergy Vision hires Caroline Loder and Natalie Ferguson

November 3, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synergy Vision

Synergy Vision, the London-based medical communications agency, has hired Caroline Loder as a senior medical writer and Natalie Ferguson as a …

e

Teva sees modest growth as US sales fall

November 3, 2011
Business Services, Sales and Marketing Teva, generics

Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …

Doctors decry cost-cutting in HIV treatment

November 2, 2011
Sales and Marketing HIV, NHS, Reyataz

Doctors in London are opposing a decision to switch HIV patients to a cheaper drug, saying it could harm patients. …

Richard Daniell appointed as managing director of Teva UK

November 2, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Teva Pharmaceutical

Richard Daniell has been appointed as managing director for Teva UK, and will be responsible for all Teva’s commercial activities …

Sanofi HQ pic

Sanofi to become world’s biggest drug maker

November 2, 2011
Medical Communications, Research and Development, Sales and Marketing Pfizer, Sanofi, top 10

Sanofi will replace Pfizer as the world’s biggest drug maker by revenue next year, according to new forecasts.  Pfizer’s nine-year …

pfizer_hq_street_web

Prevnar and Lyrica lift Pfizer results

November 1, 2011
Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry

Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter.  …

picture_2

Lundbeck appoints two new R&D vice presidents

November 1, 2011
Research and Development Lundbeck, R&D

Lundbeck has appointed Jens Peter Balling and Iman Barilero as vice presidents of its research and development organisation. The new …

Obama image

Obama takes action to curb medicine shortages

November 1, 2011
Manufacturing and Production, Research and Development, Sales and Marketing FDA, Obama, drugs

US President Barack Obama has ordered the FDA and Department of Justice to take action to reduce and prevent medicine …

Lonza image

Lonza sees continued recovery in third quarter

November 1, 2011
Manufacturing and Production, Sales and Marketing Lonza, Q3, manufacturing and production

Revenue growth at contract manufacturing organisation Lonza in the third quarter was once again undermined by the strength of the …

Pradaxa

NICE U-turn on Boehringer’s Pradaxa

November 1, 2011
Sales and Marketing NICE, Pradaxa

NICE is now recommending Boehringer Ingelheim’s Pradaxa for stroke prevention after initially rejecting the drug on cost-effectiveness issues. NICE has …

Shadow Commissioning Board goes live

October 31, 2011
Medical Communications Commissioning Board, DH, NHS

The NHS Commissioning Board, the new central and powerful committee that will co-ordinate the health service in England, has been …

UK researchers claim advance in chiral manufacturing

October 31, 2011
Manufacturing and Production Cambridge University, chiral manufacturig, chiral manufacturing

Researchers from the UK says a new technique which uses metal surfaces as templates to make drug compounds with specific …

Helen Tayton-Martin

Working Life: Adaptimmune’s Helen Tayton-Martin

October 31, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Working Life

Helen Tayton-Martin who is an executive director at Adaptimmune, talks to Pharmafocus about her role and working in cell therapy. …

Contract research news in brief

October 31, 2011
Manufacturing and Production, Research and Development CRO, manufacturing and production

PPD looks set to go private, WuXi and Quintiles stride down the acquisition trail plus updates from TrialReach and Aragen …

Avastin pack shot

FDA’s rejection of Avastin creates conflict

October 31, 2011
Research and Development, Sales and Marketing FDA, avastin, breast cancer

Oncology experts have expressed concern at the FDA’s rejection of Roche’s Avastin for the treatment of advanced breast cancer. A …

peter_maag

Carsten Schroeder appointed interim president of Novartis Diagnostics

October 31, 2011
Sales and Marketing Novartis

Schroeder was previously vice president of Novartis Diagnostics for commercial operations in Europe, the Middle East and Africa. He will …

Swiss protest image

Novartis job cuts protest

October 31, 2011
Manufacturing and Production, Sales and Marketing Novartis, job cuts, manufacturing and production

Protesters have been demonstrating outside the home of Novartis chairman Daniel Vasella and in the streets of Basel, Switzerland, in …

Core products boost Merck’s results

October 31, 2011
Medical Communications, Sales and Marketing Gardasil, Merck, Victrelis

Sales of core products and favourable exchange rates have helped Merck grow its revenue in a tough environment.  Worldwide sales …

The Gateway to Local Adoption Series

Latest content